This announcement is a separate document:
*ST景峰：摩根士丹利证券（中国）有限公司关于湖南景峰医药有限公司2016年面向合格投资者公开发行公司债券（第一期）受托管理事务临时报告
*ST Jingfeng: Interim Report of Morgan Stanley Securities (China) Co., Ltd. on the fiduciary management affairs of Hunan Jingfeng Pharmaceutical Co., Ltd.\'s public offering of corporate bonds to qualified investors in 2016 (Phase 1)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.